Research programme: anti-fungals - Elitra

Drug Profile

Research programme: anti-fungals - Elitra

Alternative Names: Anti-fungals research programme - Elitra

Latest Information Update: 19 Apr 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Concordia University; Elitra Canada (CEASED); McGill University; Natural Sciences and Engineering Research Council of Canada; University of Toronto
  • Class
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Mycoses

Most Recent Events

  • 19 Apr 2007 Discontinued - Preclinical for Mycoses in Canada (unspecified route)
  • 02 Jul 2002 This programme is still in active development
  • 22 Dec 2000 Mycota Biosciences has been acquired by Elitra Pharmaceuticals and renamed Elitra Canada
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top